Navigation Links
Cardio Vascular Medical Device Announces Forward Stock Split
Date:12/2/2009

HAIFA, Isreal, December 2 /PRNewswire-FirstCall/ -- Cardio Vascular Medical Device Corp. (CVSL.OB), a leading developer of advanced cardiovascular surgery technology, today announced that the company's Board of Directors approved a one-for-three forward stock split, in the form of a stock dividend, payable to Cardio Vascular Medical Device shareholders.

The Company will announce in due course the estimated date the stock split will be payable and the related record date of the shareholders. The stock split is subject to FINRA approval. When the forward stock split becomes effective, shareholders of common stock will receive an additional two shares for each share held at the record date.

"We are pleased to announce this forward stock split for our shareholders," stated Eli Gonen, CEO of Cardio Vascular Medical Device Corp. "We expect that the Board's decision will improve liquidity and trading volume in our company's stock."

About Cardio Vascular Medical Device

Cardio Vascular Medical Device holds a US patent for an innovative next-generation "steerable guidewire" applicable for all angioplasty (PCTA) procedures. The technology hinges on a bendable tip that improves guidewire performance, enables faster procedure completion, and provides cost benefits for patients as well as healthcare providers. The guidewire has a unique opportunity to become the guidewire of choice for surgeons throughout the world.

Learn more about Cardio Vascular Medical Device at: http://www.cvslmedical.com

Forward-Looking Statements

This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Cardio Vascular Medical Device Corp. and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated in the forward-looking statements. Cardio Vascular Medical Device Corp. public filings may be viewed at http://www.sec.gov.


    Contact:

    Alex Traiman
    Media Relations
    +1-646-863-9729

    Asher Zwebner
    +972-54-464-6363
    asher@fxmng.com


SOURCE Cardio Vascular Medical Device Corp.


'/>"/>
SOURCE Cardio Vascular Medical Device Corp.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Zargis Cardioscan(TM) Featured on The Early Show on CBS
2. CardioGenics Provides Update on Agreement with Merck Chimie for Its Silver Coated Paramagnetic Beads
3. MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices
4. Reportlinker Adds Cardiovascular Catheters and Systems - Global Market Opportunities
5. Zargis to Release Trial Version of Cardioscan while Exhibiting with 3M(TM) Littmann(R) at American Heart Association Conference
6. CardioGenics Holdings Inc. Featured in Medical Device Daily
7. eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon
8. Cardio Vascular Medical Device Launches Corporate Website
9. Cardiogenesis Reports Third Quarter 2009 Results
10. Thoratec Reports 14 Percent Growth in Cardiovascular Division Sales as Third Quarter Revenues Increase Nine Percent
11. ATS Medical to Participate in the 2009 Canaccord Adams Cardiovascular Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe ... from the David Geffen School of Medicine at UCLA. He trained in Internal Medicine ... his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions today ... cultivation and processing operations at its production facility, and opened its first two ... the manufacturer of a complete system of proactive air and surface purification solutions ...
Breaking Medicine News(10 mins):